8-K BridgeBio Pharma, Inc. 2026-08-31: filing_items
| Value | {"items": {"8.01": "Other Events", "9.01": "Financial Statements and Exhibits"}, "value": "8.01,9.01"} |
|---|---|
| Period | (as of 2026-08-31) |
| Status | current |
| Entity | 8-K BridgeBio Pharma, Inc. 2026-08-31 |
Provenance
Source: SEC EDGAR 8-K — amtlicher Ereignisstrom (Current Reports) (Public Domain (17 U.S.C. §105))
Reference: https://www.sec.gov/Archives/edgar/data/1743881/000114036126035055/0001140361-26-035055-in
Retrieved: 2026-08-31T22:09:22.278419+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/e334bd4d-8379-4c4d-8b00-7d4eb821becd
Source: SEC EDGAR 8-K — amtlicher Ereignisstrom (Current Reports) (Public Domain (17 U.S.C. §105))
Reference: https://www.sec.gov/Archives/edgar/data/1743881/000114036126035055/0001140361-26-035055-in
Retrieved: 2026-08-31T22:09:22.278419+02:00
Raw response sha256:
1ccbd93404bbe9c6f3b59864b99e1626…Cite as: FACTANKER, https://factanker.com/fact/e334bd4d-8379-4c4d-8b00-7d4eb821becd
History
- no predecessors — first report